一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> British Journal of Pharmacology >>article
British Journal of Pharmacology

British Journal of Pharmacology

IF: 6.8
Download PDF

Targeting Na+/K+-ATPase by berbamine and ouabain synergizes with sorafenib to inhibit hepatocellular carcinoma

Published:1 November 2021 DOI: 10.1111/bph.15616 PMID: 34233013
Songpeng Yang, Shu Yang, Hongying Zhang, Hui Hua, Qingbin Kong, Jiao Wang, Yangfu Jiang

Abstract

Background and purpose: The multikinase inhibitor sorafenib is a first-line drug for advanced hepatocellular carcinoma. The response to sorafenib varies among hepatocellular carcinoma patients and many of the responders suffer from reduced sensitivity after long-term treatment. This study aims to explore a novel strategy to potentiate or maximize the anti-hepatocellular carcinoma effects of sorafenib.

Experimental approach: We used hepatocellular carcinoma cell lines, western blotting, various antagonists, siRNA and tumour xenografts mouse model to determine the anti- hepatocellular carcinoma effects of sorafenib in combination with berbamine or other Na+ /K+ -ATPase ligands.

Key results: Berbamine and the cardiotonic steroid, ouabain, synergize with sorafenib to inhibit hepatocellular carcinoma cells growth. Mechanistically, berbamine induces Src phosphorylation in Na+ /K+ -ATPase-dependent manner, leading to the activation of p38MAPK and EGFR-ERK pathways. The Na+ /K+ -ATPase ligand ouabain also induces Src, EGFR, type I insulin-like growth factor receptor, ERK1/2 and p38MAPK phosphorylation in hepatocellular carcinoma cells. Treatment of hepatocellular carcinoma cells with Src or EGFR inhibitor inhibits the induction of ERK1/2 phosphorylation by berbamine. Moreover, sorafenib inhibits the induction of Src, p38MAPK, EGFR and ERK1/2 phosphorylation by berbamine and ouabain. Importantly, combination of sorafenib with berbamine or ouabain synergistically inhibits both sorafenib-na?ve and sorafenib-resistant hepatocellular carcinoma cells growth. Co-treatment of hepatocellular carcinoma cells with berbamine and sorafenib significantly induces cell death and significantly inhibits hepatocellular carcinoma xenografts growth in vivo.

Conclusion and implications: Berbamine or other Na+ /K+ -ATPase ligands have a potential for improving sorafenib responsiveness in hepatocellular carcinoma. Targeting Na+ /K+ -ATPase represents a novel strategy to potentiate the anti- hepatocellular carcinoma effects of sorafenib.

Substances (17)

Materials Related products
Procduct Name CAS Molecular Formula Supplier Price
Gefitinib 184475-35-2 C22H24ClFN4O3 827 suppliers $5.00-$1191.00
Gefitinib 184475-35-2 C22H24ClFN4O3 827 suppliers $5.00-$1191.00
Gefitinib 184475-35-2 C22H24ClFN4O3 827 suppliers $5.00-$1191.00
Gefitinib 184475-35-2 C22H24ClFN4O3 827 suppliers $5.00-$1191.00
SB 202190 152121-30-7 C20H14FN3O 291 suppliers $12.00-$1949.90
SB 202190 152121-30-7 C20H14FN3O 291 suppliers $12.00-$1949.90
SB 202190 152121-30-7 C20H14FN3O 291 suppliers $12.00-$1949.90
SB 202190 152121-30-7 C20H14FN3O 291 suppliers $12.00-$1949.90
Saracatinib 379231-04-6 C27H32ClN5O5 223 suppliers $14.00-$1920.00
Saracatinib 379231-04-6 C27H32ClN5O5 223 suppliers $14.00-$1920.00

Similar articles

IF:3.3

MOTS-c relieves hepatocellular carcinoma resistance to TRAIL-induced apoptosis under hypoxic conditions by activating MEF2A

Experimental cell research Haiying Shen, Junjie Nie,etc Published: 22 November 2024
IF:3

DSN1 Interaction With Centromere‐Associated Proteins Promotes Chromosomal Instability in Hepatocellular Carcinoma

Molecular Carcinogenesis Hongrui Zhou, Mengxue Zhang,etc Published: 19 November 2024
IF:4.6

Targeting cuproptosis by zinc pyrithione in triple-negative breast cancer.

iScience Xu Yang,?Li Deng,etc Published: 16 October 2023
甘南县| 攀枝花市| 九寨沟县| 高邑县| 洛扎县| 巴塘县| 南阳市| 镇原县| 灵璧县| 兴隆县| 霞浦县| 商洛市| 龙海市| 江口县| 大荔县| 临夏市| 广灵县| 开鲁县| 静乐县| 穆棱市| 滨海县| 武宣县| 上蔡县| 宁津县| 阿巴嘎旗| 和硕县| 武汉市| 信丰县| 长岭县| 股票| 钦州市| 稷山县| 定安县| 如皋市| 右玉县| 武平县| 景洪市| 沈丘县| 云阳县| 静海县| 巨鹿县|